Inventor
SURBER MARK WILLIAM
US14 patents
⚠️ This page may combine multiple inventors who share the name “SURBER MARK WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVALYN PHARMA INC
12 patentsUS10610536B2Apr 7, 2020
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC5 citations82
US10105356B2Oct 23, 2018
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC8 citations82
US10028966B2Jul 24, 2018
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC8 citations82
US11559520B2Jan 24, 2023
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC4 citations73
US11452718B2Sep 27, 2022
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC3 citations71
US11224592B2Jan 18, 2022
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC3 citations71
US11071741B2Jul 27, 2021
Aerosol pirfenidone and pyridone analog compound and uses thereof
AVALYN PHARMA INC3 citations71
US12090225B2Sep 17, 2024
Specially formulated compositions of inhaled nintedanib and nintedanib salts
AVALYN PHARMA INC0 citations62
US11123290B2Sep 21, 2021
Specially formulated compositions of inhaled nintedanib and nintedanib salts
AVALYN PHARMA INC1 citations62
US12226407B2Feb 18, 2025
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC0 citations61
US12023342B2Jul 2, 2024
Aerosol pirfenidone and pyridone analog compounds and uses thereof
AVALYN PHARMA INC0 citations61
US11980689B2May 14, 2024
Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)
AVALYN PHARMA INC1 citations61